These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8108461)

  • 41. Overexpression of interleukin-6 aggravates viral myocarditis: impaired increase in tumor necrosis factor-alpha.
    Tanaka T; Kanda T; McManus BM; Kanai H; Akiyama H; Sekiguchi K; Yokoyama T; Kurabayashi M
    J Mol Cell Cardiol; 2001 Sep; 33(9):1627-35. PubMed ID: 11549342
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sex-dependent, early cytokine production by NK-like spleen cells following infection with the D variant of encephalomyocarditis virus (EMCV-D).
    McFarland HI; Bigley NJ
    Viral Immunol; 1989; 2(3):205-14. PubMed ID: 2560916
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Therapeutic effect of anti-tumor necrosis factor-alpha antibody on the murine model of viral myocarditis induced by encephalomyocarditis virus.
    Yamada T; Matsumori A; Sasayama S
    Circulation; 1994 Feb; 89(2):846-51. PubMed ID: 8313574
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Innate immune response to encephalomyocarditis virus infection mediated by CD1d.
    Exley MA; Bigley NJ; Cheng O; Shaulov A; Tahir SM; Carter QL; Garcia J; Wang C; Patten K; Stills HF; Alt FW; Snapper SB; Balk SP
    Immunology; 2003 Dec; 110(4):519-26. PubMed ID: 14632651
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pathogenesis of the B variant of encephalomyocarditis virus.
    Shafi R; Cerutis DR; Giron DJ
    J Med Virol; 1993 Jul; 40(3):193-9. PubMed ID: 8394871
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Experimental encephalomyocarditis virus infection in Mongolian gerbils (Meriones unguiculatus).
    Matsuzaki H; Doi K; Mitsuoka T; Tsuda T; Onodera T
    Vet Pathol; 1989 Jan; 26(1):11-7. PubMed ID: 2536510
    [TBL] [Abstract][Full Text] [Related]  

  • 47. D variant of encephalomyocarditis virus (EMCV-D)-induced diabetes following natural killer cell depletion in diabetes-resistant male C57BL/6J mice.
    White LL; Smith RA
    Viral Immunol; 1990; 3(1):67-76. PubMed ID: 2153386
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pancreatitis of mice infected with encephalomyocarditis virus.
    Burch GE; Tsui CY; Harb JM
    Pathol Microbiol (Basel); 1974; 40(5):281-96. PubMed ID: 4365521
    [No Abstract]   [Full Text] [Related]  

  • 49. Outbred mice infected by an encephalomyocarditis virus variant: a model for studying chronic viral heart disease.
    Kruppenbacher JP; Arnold G; Mertens T; Fischer A; Zimmermann J; Eggers HJ
    Virchows Arch A Pathol Anat Histopathol; 1993; 422(5):405-13. PubMed ID: 8391736
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Embryonic stem cells attenuate viral myocarditis in murine model.
    Wang JF; Yang Y; Wang G; Min J; Sullivan MF; Ping P; Xiao YF; Morgan JP
    Cell Transplant; 2002; 11(8):753-8. PubMed ID: 12588107
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synergistic effects of tacrolimus and human interferon-alpha A/D in murine viral myocarditis.
    Kanda T; Nagaoka H; Kaneko K; Wilson JE; McManus BM; Imai S; Suzuki T; Murata K; Kobayashi I
    J Pharmacol Exp Ther; 1995 Jul; 274(1):487-93. PubMed ID: 7542339
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Propranolol ameliorates and epinephrine exacerbates progression of acute and chronic viral myocarditis.
    Wang JF; Meissner A; Malek S; Chen Y; Ke Q; Zhang J; Chu V; Hampton TG; Crumpacker CS; Abelmann WH; Amende I; Morgan JP
    Am J Physiol Heart Circ Physiol; 2005 Oct; 289(4):H1577-83. PubMed ID: 15923319
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acute infection of encephalomyocarditis (EMC) virus in Syrian hamsters.
    Sugawara Y; Hirasawa K; Takeda M; Han JS; Doi K
    J Vet Med Sci; 1991 Jun; 53(3):463-8. PubMed ID: 1653039
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Exploitation of nuclear protein SFPQ by the encephalomyocarditis virus to facilitate its replication.
    Zhou B; Wu F; Han J; Qi F; Ni T; Qian F
    Biochem Biophys Res Commun; 2019 Feb; 510(1):65-71. PubMed ID: 30661786
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of viruses in type I diabetes: two distinct cellular and molecular pathogenic mechanisms of virus-induced diabetes in animals.
    Jun HS; Yoon JW
    Diabetologia; 2001 Mar; 44(3):271-85. PubMed ID: 11317656
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of invariant NKT cells in lipopolysaccharide-induced lethal shock during encephalomyocarditis virus infection.
    Ando T; Ito H; Ohtaki H; Kanbe A; Hirata A; Hara A; Seishima M
    Immunobiology; 2017 Feb; 222(2):350-357. PubMed ID: 27665995
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparative study of the pathogenic properties of a Belgian and a Greek encephalomyocarditis virus (EMCV) isolate for sows in gestation.
    Koenen F; Vanderhallen H
    Zentralbl Veterinarmed B; 1997 Jul; 44(5):281-6. PubMed ID: 9270350
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Virus-induced diabetes mellitus: VIII. Passage of encephalomyocarditis virus and severity of diabetes in susceptible and resistant strains of mice.
    Yoon J; Onodera T; Notkins AL
    J Gen Virol; 1977 Nov; 37(2):225-32. PubMed ID: 200705
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increased severity of viral myocarditis in mice lacking lymphocyte maturation.
    Kanda T; Koike H; Arai M; Wilson JE; Carthy CM; Yang D; McManus BM; Nagai R; Kobayashi I
    Int J Cardiol; 1999 Jan; 68(1):13-22. PubMed ID: 10077396
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Analysis of sequence and pathogenic properties of two variants of encephalomyocarditis virus differing in a single amino acid in VP1.
    Nelsen-Salz B; Zimmermann A; Wickert S; Arnold G; Botta A; Eggers HJ; Kruppenbacher JP
    Virus Res; 1996 Apr; 41(2):109-22. PubMed ID: 8738170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.